arenavirus
larg
famili
emerg
negativestrand
rna
virus
includ
sever
sever
human
pathogen
caus
hemorrhag
fever
high
mortal
arenaviru
life
cycl
process
viral
envelop
glycoprotein
precursor
gpc
cellular
subtilisin
kexin
proteas
crucial
product
infect
abil
newli
emerg
arenavirus
hijack
human
key
factor
zoonot
transmiss
human
diseas
potenti
apart
essenti
host
factor
arenaviru
infect
involv
regul
import
physiolog
process
link
major
human
diseas
chapter
provid
overview
mechan
arenaviru
gpc
process
includ
recent
find
highlight
extent
molecular
mechan
cleavag
viral
gpc
differ
process
cellular
substrat
discuss
implic
virushost
interact
coevolut
moreov
show
use
viral
gpc
molecular
probe
uncov
novel
unusu
aspect
biosynthesi
matur
crucial
role
arenaviru
infect
major
human
diseas
combin
natur
enzym
make
attract
target
therapeut
intervent
last
part
therefor
cover
past
present
effort
identifi
specif
inhibitor
sever
excel
review
cover
differ
step
arenaviru
life
cycl
fehl
et
al
grant
et
al
emonet
et
al
torriani
et
al
nunberg
york
wolff
et
al
loureiro
et
al
short
summari
given
first
step
arenaviru
infect
requir
attach
viral
particl
cellular
receptor
old
world
clade
c
new
world
arenavirus
use
dystroglycan
ubiquit
express
receptor
protein
extracellular
matrix
ecm
highaffin
receptor
cao
et
al
oldston
campbel
cellular
receptor
pathogen
clade
b
new
world
arenavirus
identifi
human
transferrin
receptor
radoshitzki
et
al
highli
conserv
cargo
receptor
involv
iron
metabol
abil
clade
b
new
world
arenaviru
use
human
crucial
potenti
caus
zoonot
infect
hemorrhag
fever
man
wherea
nonpathogen
virus
use
orthologu
speci
helguera
et
al
radoshitzki
et
al
recent
mer
tam
receptor
tyrosin
kinas
axl
cell
immunoglobulin
mucin
tim
protein
well
ctype
lectin
dcspecif
nonintegrin
dcsign
lsectin
identifi
novel
candid
receptor
arenavirus
jemiel
et
al
goncalv
et
al
martinez
et
al
upon
initi
attach
target
cell
arenaviru
particl
taken
receptormedi
endocytosi
consist
use
receptor
clade
b
new
world
virus
enter
via
clathrinmedi
endocytosi
martinez
et
al
wherea
old
world
arenavirus
use
pathway
resembl
macropinocytosi
iwasaki
et
al
opplig
et
al
torriani
et
al
viru
pass
multivesicular
endosom
reach
late
endosom
pasqual
et
al
low
ph
trigger
fusion
viral
membran
limit
membran
late
endosom
fusionact
creat
fusion
pore
late
endosom
lasv
undergo
uniqu
receptor
switch
engag
late
endosomallysosom
resid
protein
effici
fusion
jae
et
al
depend
lasv
arenavirus
includ
close
relat
lcmv
late
endosom
entri
factor
repres
interest
analog
filovirus
ebola
viru
whose
fusion
depend
late
endosom
protein
niemannpick
jae
brummelkamp
unknown
mechan
uncoat
arenaviru
ribonucleoprotein
rnp
compris
viral
rna
np
l
releas
cytosol
viral
transcript
initi
incom
polymeras
complex
result
express
np
l
np
accumul
viral
polymeras
shift
replicas
mode
gener
fulllength
antigenom
rna
serv
templat
transcript
gpc
z
well
synthesi
genom
rna
newli
synthes
np
assembl
viral
replicationtranscript
complex
membraneassoci
structur
contain
cellular
lipid
protein
baird
et
al
knopp
et
al
final
stage
arenaviru
life
cycl
progeni
particl
assembl
releas
bud
plasma
membran
key
factor
bud
process
small
ring
finger
z
protein
function
bona
fide
matrix
protein
arenaviru
particl
assembl
perez
et
al
matrix
protein
envelop
virus
arenaviru
z
interact
cytosol
tail
capul
et
al
specif
cellular
factor
endosomalmultipl
vesicl
bodi
pathway
drive
bud
viral
particl
bud
zone
wolff
et
al
fehl
et
al
perez
et
al
recent
studi
isol
identifi
character
novel
highli
diverg
arenavirus
snake
associ
boid
inclus
bodi
diseas
bodew
et
al
hetzel
et
al
stenglein
et
al
genom
organ
virus
correspond
arenavirus
show
high
degre
diverg
notabl
gpc
viral
envelop
seem
relat
filovirus
case
infect
speci
report
far
though
reptarenavirus
capabl
infect
mammalian
arthropod
cell
vitro
hepojoki
et
al
interestingli
reptarenaviru
infect
mammalian
cell
occur
effici
markedli
reduc
mammalian
bodi
temperatur
like
highlight
adapt
reptil
host
hepojoki
et
al
preval
human
pathogen
among
arenavirus
old
world
arenaviru
lasv
caus
sever
viral
hemorrhag
fever
high
mortal
human
everi
year
lasv
caus
infect
western
africa
mccormick
fisherhoch
declar
one
eight
top
emerg
pathogen
sweileh
current
neither
effici
cure
licens
vaccin
result
case
fatal
rate
yun
walker
usa
junv
macv
gtov
sabv
emerg
caus
agent
hemorrhag
fever
high
casefat
rate
junv
repres
import
public
health
problem
grant
et
al
novel
arenavirus
emerg
averag
everi
year
associ
sever
diseas
bries
et
al
delgado
et
al
highli
pathogen
arenavirus
includ
list
categori
pathogen
center
diseas
control
prevent
global
climat
chang
may
influenc
popul
dynam
natur
rodent
host
popul
like
increas
exposur
human
pathogen
pathophysiolog
fatal
arenaviru
infect
well
understood
involv
viral
host
immun
factor
yun
walker
prescott
et
al
highli
predict
paramet
diseas
outcom
viral
load
indic
close
competit
viral
spread
replic
patient
immun
system
prescott
et
al
drug
target
specif
step
viral
life
cycl
reduc
multipl
spread
viru
may
provid
patient
immun
system
window
opportun
develop
antivir
immun
respons
indepth
understand
molecular
mechan
underli
arenaviru
multipl
virushost
cell
interact
therefor
great
import
develop
novel
efficaci
strategi
antivir
therapeut
intervent
arenaviru
gpc
synthes
initi
singl
polypeptid
precursor
sequenti
cleav
cellular
signal
peptidas
lenz
et
al
rojek
et
al
beyer
et
al
fig
b
process
gpc
yield
ntermin
implic
bind
cellular
receptor
borrow
oldston
transmembran
mediat
fusion
resembl
class
viral
fusion
protein
eschli
et
al
igonet
et
al
parsi
et
al
arenaviru
gpc
contain
remark
stabl
signal
peptid
ssp
amino
acid
contain
two
hydrophob
domain
undergo
myristoyl
nterminu
eichler
et
al
b
york
et
al
froeschk
et
al
ssp
becom
part
matur
tripartit
complex
ssp
interact
subunit
fig
recent
electron
cryomicroscopi
combin
tomographi
reveal
complex
lasv
assembl
trimer
spike
nm
high
nm
wide
undergo
signific
chang
expos
low
ph
li
et
al
structur
studi
lasv
macv
junv
reveal
similar
compact
fold
despit
signific
sequenc
deviat
bowden
et
al
cohendvashi
et
al
mahmutov
et
al
structur
studi
complex
macv
cellular
receptor
reveal
monom
repres
function
unit
receptor
recognit
trimer
requir
receptor
bind
abraham
et
al
radoshitzki
et
al
notabl
macv
bind
apic
surfac
without
compet
transferrin
bind
recent
crystallograph
studi
resolv
structur
prefus
conform
matur
envelop
gp
prototyp
old
world
arenaviru
lcmv
hasti
et
al
within
prefus
trimer
lcmv
undergo
extens
interact
involv
ionic
bond
contrast
new
world
arenavirus
monomer
lcmv
unabl
bind
receptor
dystroglycan
high
affin
suggest
either
avid
quaternari
structur
prefus
trimer
requir
deliv
late
endosom
low
ph
set
seri
conform
chang
lead
shed
trigger
fusion
viral
cellular
membran
mediat
fig
postfus
conform
arenaviru
similar
sixhelix
bundl
conform
common
number
class
fusion
protein
envelop
virus
igonet
et
al
parsi
et
al
ssp
crucial
transport
process
arenaviru
gpc
messina
et
al
york
nunberg
york
et
al
eichler
et
al
b
nand
ctermini
ssp
locat
cytosol
agnihothram
et
al
ssp
associ
noncoval
zincbind
domain
within
cytoplasm
tail
agnihothram
et
al
briknarova
et
al
interact
critic
modul
phinduc
activ
membran
fusion
nunberg
target
rang
potent
arenaviru
fusion
inhibitor
shankar
et
al
york
et
al
pinpoint
uniqu
featur
arenaviru
fusion
target
develop
antivir
therapeut
crucial
step
arenaviru
infect
matur
envelop
glycoprotein
precursor
gpc
except
crimeancongo
hemorrhag
fever
viru
belong
bunyaviru
famili
mammarenavirida
viral
pathogen
known
hijack
proprotein
convertas
process
envelop
gp
proprotein
convertas
pc
famili
nine
conserv
calciumdepend
serin
endoproteas
includ
basic
pc
furin
well
nonbas
pc
seidah
prat
pc
share
homolog
kexin
subfamili
subtilas
distinct
serhisasp
catalyt
triad
mediat
peptid
bond
scission
seidah
prat
furin
membraneanchor
remain
enzym
secret
retain
granul
seidah
basic
pc
similar
ident
consensu
sequenc
may
result
overlap
pattern
substrat
cleavag
contrast
cleav
hydrophob
small
residu
bx
hydrophob
pasquato
et
al
respect
benjannet
et
al
process
pc
essenti
proper
function
plethora
cellular
protein
includ
prohormon
growth
factor
precursor
transcript
factor
proteas
adhes
molecul
convertas
codiscov
laboratori
nabil
seidah
work
biosynthesi
brainderiv
neurotroph
factor
seidah
et
al
group
brown
goldstein
investig
regul
cholesterol
metabol
sakai
et
al
type
membran
protein
synthes
inact
precursor
amino
acid
compris
signal
peptid
ntermin
prodomain
catalyt
domain
fig
transmembran
domain
follow
basic
cytosol
tail
amino
acid
pc
activ
requir
remov
ntermin
prodomain
assist
correct
fold
proteas
fig
upon
transloc
er
undergo
autocatalyt
matur
sequenti
cleavag
ntermin
prodomain
first
site
follow
site
c
rrll
newli
describ
site
rra
da
palma
et
al
end
product
c
form
repres
fulli
matur
enzym
tour
et
al
elagoz
et
al
contrast
basic
pc
matur
uniqu
fragment
truncat
prodomain
remain
attach
catalyt
subunit
proteas
fig
retent
prodomain
prevent
catalyt
activ
basic
pc
complex
attach
prodomain
fragment
enzymat
activ
may
differ
interact
cellular
viral
substrat
detail
da
palma
et
al
fig
use
gpc
arenavirus
molecular
probe
recent
studi
reveal
prodomain
modular
structur
specif
ntermin
ab
fragment
repres
autonom
structur
function
unit
necessari
suffici
fold
partial
activ
da
palma
et
al
contrast
ctermin
bc
fragment
prodomain
lack
defin
structur
seem
crucial
autoprocess
full
activ
ab
sequenc
prodomain
evolutionari
highli
conserv
wherea
bc
fragment
show
consider
variat
even
miss
speci
phylogenet
function
studi
suggest
primordi
may
contain
simpler
prodomain
consist
conserv
ab
fragment
wherea
bc
region
appear
later
evolutionari
acquisit
possibl
allow
subtl
regul
matur
process
da
palma
et
al
play
key
role
regul
lipid
metabol
physiolog
process
link
wide
rang
human
disord
includ
hypercholesterolemia
vascular
diseas
cancer
viral
infect
fig
proven
role
human
diseas
natur
enzym
make
interest
target
therapeut
intervent
activ
first
link
cholesterol
fatti
acid
biosynthesi
implic
activ
sterol
regul
protein
factor
srebp
sakai
et
al
transcript
factor
shown
activ
manner
includ
activ
transcript
factor
atf
sens
er
stress
ye
et
al
member
camp
respons
elementbind
protein
creb
famili
kondo
et
al
substrat
share
similar
mechan
activ
involv
process
follow
cleavag
proteas
initi
ratelimit
process
occur
lumen
golgi
compart
secretori
pathway
cleavag
unmask
unusu
mechan
matur
synthes
inact
zymogen
precursor
undergo
autocatalyt
cleavag
remov
prodomain
signal
peptid
sp
prodomain
catalyt
domain
shed
site
transmembran
domain
well
autoprocess
site
correspond
amino
acid
sequenc
indic
autoprocess
site
c
gener
matur
enzym
b
schemat
represent
matur
prototyp
basic
pc
furin
left
right
initi
autoprocess
furin
prodomain
result
catalyt
inact
latent
complex
prodomain
enzym
complet
remov
prodomain
requir
liber
activ
enzym
late
secretori
pathway
contrast
immatur
form
contain
prodomain
fragment
differ
length
present
along
secretori
pathway
catalyt
activ
c
process
site
resembl
site
b
c
autoprocess
detail
pleas
see
text
second
site
process
locat
close
cytosol
face
membran
subsequ
cleav
metalloproteas
process
releas
solubl
fragment
cytosol
subsequ
enter
nucleu
act
transcript
regul
addit
transcript
factor
implic
process
probrainderiv
neurotroph
factor
seidah
et
al
gnptab
respons
correct
sort
lysosom
protein
marschner
et
al
renin
receptor
nakagawa
et
al
play
role
bone
muscl
format
gorski
et
al
gorski
et
al
ecm
signal
axial
develop
achilleo
et
al
well
fur
pigment
rutschmann
et
al
howev
exact
substrat
involv
latter
process
yet
clearli
identifi
align
put
cleavag
site
arenaviru
gpc
reveal
extens
sequenc
variat
tabl
due
unusu
residu
pattern
process
site
proteas
respons
gpc
cleavag
found
long
identif
consensu
motif
far
implic
process
mammarenaviru
gpc
test
includ
old
world
virus
lasv
lenz
et
al
lenz
et
al
lcmv
pinschew
et
al
beyer
et
al
distantli
relat
lujv
opplig
et
al
urata
et
al
well
new
world
arenavirus
differ
clade
rojek
et
al
pasquato
et
al
opplig
et
al
align
sequenc
surround
put
cleavag
site
posit
reveal
presenc
highli
conserv
arg
hydrophob
residu
posit
respect
fig
cellular
substrat
cellular
substrat
link
major
human
disord
b
subcellular
locat
autocatalyt
activ
process
major
cellular
substrat
detail
pleas
see
text
genbank
id
name
viru
speci
amino
acid
cleavag
site
display
conserv
r
residu
posit
hydrophob
residu
posit
highlight
matur
gpc
strictli
requir
product
infecti
particl
viral
celltocel
spread
beyer
et
al
lenz
et
al
rojek
et
al
crucial
role
arenaviru
dissemin
vivo
suggest
observ
mice
bear
wood
rat
mutat
show
enhanc
resist
infect
lcmv
due
impair
gpc
process
popkin
et
al
accordingli
proofofconcept
studi
proteinand
peptidebas
inhibitor
reveal
target
gpc
matur
repres
novel
promis
antivir
strategi
maisa
et
al
rojek
et
al
develop
inhibit
infect
cell
result
format
noninfecti
nake
particl
contain
viral
rnp
lack
gp
lenz
et
al
kunz
et
al
rojek
et
al
indic
specif
incorpor
fulli
matur
process
gp
arenaviru
bud
machineri
capabl
achiev
specif
current
unknown
notabl
process
requir
cellsurfac
transport
arenaviru
gpc
kunz
et
al
schlie
et
al
small
amount
uncleav
gpc
detect
surfac
infect
cell
kunz
et
al
howev
contrast
trimer
matur
complex
uncleav
gpc
form
monom
oligom
span
wide
size
rang
indic
process
critic
correct
oligomer
state
schlie
et
al
moreov
mutat
cytosol
tail
lcmv
lasv
affect
process
ectodomain
schlie
et
al
kunz
et
al
suggest
sort
transmiss
structur
inform
membran
sinc
viral
bud
requir
interact
cytosol
domain
matrix
protein
z
capul
et
al
process
may
requir
target
matur
gp
put
bud
domain
andor
unmask
bind
domain
z
cleavag
site
arenaviru
gpc
differ
cellular
substrat
resembl
b
c
autoprocess
motif
fig
gpc
junv
contain
sequenc
b
site
wherea
lasv
lcmv
gpc
cleav
motif
c
site
lasv
gpc
recognit
sequenc
rrll
undergo
process
earli
secretori
pathway
lenz
et
al
wherea
lcmv
gpc
contain
rrla
process
late
golgi
postgolgi
compart
wright
et
al
beyer
et
al
membraneassoci
found
predominantli
earli
golgi
cellular
substrat
cleav
pullikotil
et
al
thu
data
hand
indic
activ
least
three
differ
subcompart
secretori
pathway
ercisgolgi
lasv
gpc
median
golgi
srebp
creb
gnptab
late
golgi
lcmv
gpc
fig
arenavirus
select
specif
subcellular
compart
gpc
matur
still
fulli
understood
recent
studi
gave
hint
subtl
chang
sequenc
cleavag
site
drastic
effect
locat
effici
gpc
matur
despit
maintain
consensu
motif
exampl
process
lcmv
gpc
mutant
contain
cleavag
site
rrll
deriv
lasv
gpc
redirect
late
golgi
ercisgolgi
contrast
introduct
lcmv
gpc
cleavag
motif
rrla
lasv
gpc
backbon
result
uncleav
protein
burri
et
al
unusu
mechan
zymogen
activ
matur
describ
fig
may
contribut
phenomenon
mention
autocatalyt
process
necessari
suffici
remov
proseg
result
differ
alreadi
activ
form
enzym
still
bear
prodomain
fragment
distinct
length
fig
conceiv
enzymeprodomain
complex
locat
defin
subcompart
secretori
pathway
may
show
differenti
specif
viral
cellular
substrat
evid
differenti
recognit
viral
cellular
substrat
come
observ
mutat
within
autoprocess
site
result
select
impair
viral
gpc
process
cleavag
cellular
substrat
burri
et
al
due
nonlyt
strategi
replic
arenavirus
establish
persist
infect
vitro
vivo
without
caus
overt
sign
patholog
consid
multipl
role
maintain
cellular
function
larg
nonoverlap
subcellular
local
viral
vs
cellular
substrat
fig
may
consequ
extens
coevolut
virus
reservoir
host
accordingli
high
express
level
gpc
acut
arenaviru
infect
interfer
process
involv
host
cell
er
stress
respons
pasqual
et
al
consequ
arenaviru
infect
result
specif
transient
activ
branch
cellular
er
stress
respons
includ
upregul
chaperon
adjust
fold
capac
increas
demand
differenti
subcellular
locat
process
viral
cellular
substrat
may
therefor
allow
extens
viral
replic
gene
express
without
caus
overt
cytopath
effect
oldston
comparison
current
known
sequenc
arenaviru
gpc
reveal
presenc
highli
conserv
aromat
residu
posit
rel
recognit
site
old
world
clade
c
new
world
arenavirus
new
world
virus
clade
b
cellular
substrat
burri
et
al
tabl
earli
experiment
evid
alreadi
support
notion
aromat
amino
acid
somehow
promot
cleavag
lasv
pasquato
et
al
lcmv
gpc
beyer
et
al
subsequ
molecular
model
allow
dock
lasv
gpcderiv
peptid
put
catalyt
pocket
burri
et
al
studi
reveal
aromat
signatur
residu
posit
viral
gpc
recognit
sequenc
interact
residu
locat
extend
substratebind
pocket
burri
et
al
inde
introduct
mutat
give
enzym
markedli
impair
process
lasv
gpc
gpc
new
world
arenavirus
cellular
substrat
coevolut
mammalian
host
gpc
old
world
clade
c
new
world
virus
appar
expand
molecular
contact
beyond
classic
four
amino
acid
recognit
sequenc
result
enlarg
bind
surfac
concept
critic
residu
flank
classic
recognit
site
modul
pc
process
also
support
find
basic
pc
cellular
substrat
compar
studi
show
influenc
surround
amino
acid
rel
pc
cleavag
effici
remacl
et
al
presenc
n
posit
scissil
bond
substrat
growth
differenti
markedli
reduc
cleavag
furin
select
permiss
essalmani
et
al
moreov
constam
colleagu
demonstr
l
g
posit
nodal
regul
fate
pluripot
cell
dramat
enhanc
basic
pc
process
support
concept
constam
robertson
specif
interact
aromat
residu
lasv
gpc
process
cleavag
cellular
substrat
make
interact
promis
target
develop
specif
antivir
drug
import
human
pathogen
perturb
interact
highli
conserv
aromat
side
chain
posit
lasv
gpc
contact
residu
eg
small
molecul
expect
affect
catalyt
triad
limit
unwant
side
effect
markedli
reduc
process
lasv
gpc
bear
mutat
posit
burri
et
al
suggest
viral
escap
variant
lack
aromat
signatur
residu
may
impair
fit
make
interact
true
achil
heel
viru
mammarenavirida
sever
line
evid
suggest
matur
viral
gpc
crucial
step
viru
life
cycl
contrast
littl
known
biosynthesi
matur
process
reptarenaviru
gpc
sequenc
reptarenaviru
gpc
seem
deviat
canon
composit
mammarenavirus
bear
resembl
filoviru
gp
li
et
al
stenglein
et
al
contrast
arenaviru
gpc
whose
process
critic
depend
gp
filoviru
ebola
undergo
process
furin
prototyp
member
basic
pc
famili
although
cleavag
seem
dispens
viru
infect
propag
neumann
et
al
see
also
chap
studi
requir
identifi
specif
cellular
proteas
involv
reptarenaviru
gpc
process
see
step
crucial
function
matur
differ
mechan
rule
includ
use
anoth
class
hostderiv
proteas
may
function
secretori
pathway
biosynthesi
cell
surfac
entri
process
illustr
use
endosom
cathepsin
filovirus
hunt
et
al
coronavirus
use
multipl
proteas
includ
cathepsin
cell
surfac
transmembran
proteaseserin
proteas
furin
trypsin
millet
whittak
see
also
chap
major
challeng
develop
drug
human
pathogen
arenavirus
limit
structur
inform
avail
pathogen
virus
arenavirus
critic
depend
molecular
machineri
host
cell
multipl
particularli
true
biosynthesi
envelop
gp
involv
complex
interplay
cellular
factor
includ
far
human
pathogen
arenavirus
seem
activ
crucial
product
infect
absenc
activ
infect
cell
produc
noninfecti
nake
particl
devoid
gp
due
yetunknown
mechan
select
incorpor
cleav
gp
studi
carri
investig
abil
arenavirus
escap
recombin
lcmv
contain
furin
cleavag
site
instead
found
replic
compet
behav
similarli
wildtyp
viru
cell
cultur
rojek
et
al
although
suggest
arenavirus
may
least
principl
use
proteas
gpc
process
persist
viru
infect
null
cell
inhibitor
treatment
far
never
result
emerg
viral
escap
variant
rojek
et
al
rojek
et
al
pasquato
et
al
moreov
complet
inhibit
seem
requir
restrict
arenaviru
infect
vivo
sinc
partial
activ
wood
rat
variant
enzym
confer
signific
protect
prevent
persist
viral
infect
lcmv
popkin
et
al
sum
inhibit
appear
promis
therapeut
approach
combat
arenaviru
infect
pasquato
et
al
direct
inhibit
matur
proteas
wide
use
approach
interfer
normal
enzymat
activ
although
approach
often
give
excel
result
catalyt
dead
enzym
result
gener
loss
activ
toward
substrat
cellular
viral
alik
unwant
side
effect
must
care
taken
consider
consid
crucial
role
major
physiolog
process
disord
includ
infect
highli
pathogen
arenaand
bunyavirus
effort
made
develop
panel
proteinbas
small
molecul
inhibitor
cover
natur
occur
serpin
antitrypsin
long
known
potent
suicid
inhibitor
trypsinlik
proteas
entrap
enzym
stabl
complex
follow
cleavag
reactiv
site
loop
subsequ
mutat
insert
reactiv
site
loop
introduc
b
x
n
motif
basic
pc
yield
potent
proteinbas
furin
inhibitor
pdx
anderson
et
al
base
homolog
catalyt
site
basic
nonbas
pc
reactiv
site
loop
mutat
introduc
bx
hydrophob
motif
rrvl
cell
cultur
experi
rrvl
effici
block
process
srebp
overexpress
rrvl
inhibit
lasv
gpc
matur
strong
antivir
effect
markedli
reduc
celltocel
spread
infecti
viral
particl
product
maisa
et
al
provid
proof
concept
analog
peptid
chloromethyl
keton
cmk
develop
inhibit
furinlik
proteas
two
cmk
peptid
design
contain
iyisrrl
rrll
motif
deriv
lasv
gpc
cmk
peptid
act
irrevers
inhibitor
level
substrat
matur
pasquato
et
al
proofofprincipl
studi
show
small
molecul
potent
block
infect
lcmv
rojek
et
al
howev
due
toxic
cmk
inhibitor
suitabl
therapeut
agent
aminopyrrolidin
amid
compound
revers
competit
inhibitor
discov
pfizer
inc
effici
block
process
endogen
cellular
substrat
hay
et
al
follow
administr
vivo
activ
mice
dramat
reduc
result
mark
drop
plasma
cholesterol
level
hawkin
et
al
pharmacolog
inhibit
activ
also
block
lasv
lcmv
gpc
matur
reduc
celltocel
propag
mild
offtarget
effect
pasquato
et
al
cell
persist
infect
lcmv
effici
clear
treatment
without
emerg
drugresist
viral
escap
variant
pasquato
et
al
initi
evalu
vivo
murin
model
rais
concern
applic
chronic
diseas
famili
hypercholesterolemia
hawkin
et
al
howev
human
pathogen
arenavirus
caus
acut
diseas
limit
antivir
treatment
time
window
week
consid
rel
short
period
treatment
toxicolog
pharmacokinet
profil
make
still
interest
experiment
drug
candid
hawkin
et
al
current
standard
care
treatment
human
arenaviru
infect
offlabel
use
nucleosid
analogu
ribavirin
parker
earli
administr
ribavirin
reduc
fatal
human
lassa
fever
mccormick
et
al
experiment
infect
macv
kilgor
et
al
junv
weissenbach
et
al
anim
howev
achiev
high
efficaci
ribavirin
need
administ
earli
infect
intraven
often
associ
side
effect
novel
antiarenavir
drug
may
use
individu
combin
therapi
ribavirin
combat
human
pathogen
arenavirus
allow
lower
dose
ribavirin
inde
combin
ribavirin
reveal
stronger
addit
effect
two
drug
pasquato
et
al
basi
appar
synerg
may
lie
distinct
underli
antivir
mechan
two
drug
depend
concentr
use
ribavirin
inhibit
arenaviru
infect
level
replic
ruizjarabo
et
al
show
drug
action
mutagen
moreno
et
al
contrast
affect
biosynthesi
viral
gp
block
format
infecti
progeni
viru
infect
cell
outlin
current
avail
inhibitor
potent
specif
repres
invalu
experiment
drug
proofofconcept
studi
howev
face
consider
restrict
regard
therapeut
use
clinic
medicin
protein
natur
rrvl
make
cell
permeabl
vivo
drug
deliveri
challeng
smaller
decanoyl
cmk
peptid
show
good
cell
permeabl
due
toxic
profil
short
halflif
use
restrict
low
cytotox
show
vitro
ic
low
micromolar
rang
howev
compound
unfavor
pharmacokinet
profil
vivo
best
knowledg
yet
enter
clinic
test
phase
consid
promis
drug
target
limit
candid
inhibitor
hand
identif
novel
small
molecul
inhibitor
high
prioriti
convent
approach
studi
substrat
process
use
homogen
biochem
assay
includ
synthet
chromogen
peptid
purifi
solubl
enzym
pasquato
et
al
system
greatli
contribut
current
understand
biochemistri
lead
discoveri
candid
drug
like
howev
mention
evid
accumul
interact
substrat
complex
may
also
regul
level
subcellular
locat
robust
quantifi
cellbas
assay
therefor
need
screen
inhibitor
process
specif
substrat
authent
cellular
context
close
gap
novel
reliabl
cellbas
assay
allow
quantit
detect
enzymat
activ
endogen
develop
exploit
key
find
process
viral
gpc
da
palma
et
al
assay
base
chimer
protein
compos
gaussia
luciferas
gluc
report
anchor
membran
stump
region
virusderiv
cleavabl
peptid
sequenc
fig
sequenc
use
prototyp
sensor
deriv
lasv
gpc
one
best
substrat
current
known
pasquato
et
al
lenz
et
al
assur
optim
sensit
specif
sensor
membran
anchor
sensor
mimic
allow
correct
cellular
target
favor
optim
substrateenzym
recognit
upon
process
sensor
releas
solubl
report
gluc
medium
easili
detect
use
sensit
costeffici
luciferas
assay
sensor
recapitul
key
featur
viral
substrat
process
site
deriv
term
subcellular
local
effici
cleavag
robust
reliabl
natur
novel
cellbas
sensor
assay
allow
implement
highthroughput
screen
ht
pc
essenti
normal
cell
function
develop
adult
seidah
prat
nonetheless
sever
studi
show
specif
inhibit
definit
pc
detriment
case
vivo
shortterm
treatment
hay
et
al
shiryaev
et
al
thu
target
viral
gp
cleavag
novel
promis
therapeut
approach
fight
virul
pathogen
hemorrhag
arenavirus
modern
global
world
increasingli
face
threat
emerg
virus
due
human
migrat
rapidli
progress
urban
almost
free
global
trade
exposur
anim
climat
chang
develop
novel
broadli
specif
antivir
therefor
import
help
meet
unmatch
medic
problem
new
arenavirus
rapidli
emerg
case
associ
sever
human
diseas
advent
power
nextgener
sequenc
approach
expect
see
acceler
discoveri
mani
new
arenaviru
speci
pathogen
year
come
howev
mani
case
virus
may
isol
genet
inform
becom
avail
consid
extens
variat
known
put
recognit
sequenc
known
arenaviru
gpc
defin
consensu
sequenc
easili
found
burri
et
al
pasquato
et
al
data
hand
indic
knowledg
sequenc
residu
put
cleavag
site
novel
arenaviru
gpc
would
necessari
suffici
test
new
viru
hijack
human
prerequisit
product
infect
henc
diseas
potenti
man
recent
studi
cellbas
sensor
appli
make
first
predict
recent
emerg
lujv
gpc
process
human
fig
cellbas
sensor
detect
endogen
activ
schemat
sensor
stump
region
gluc
report
well
virusderiv
peptid
compris
cleavag
motif
indic
process
sensor
endogen
releas
gluc
report
sphere
secret
tissu
cultur
supernat
detect
via
luminesc
assay
detail
pleas
see
text
phylogenet
analysi
identifi
lujv
outlier
within
old
world
arenavirus
sequenc
put
border
differ
significantli
known
consensu
burri
et
al
despit
import
differ
sensor
contain
peptid
deriv
lujv
gpc
underw
effici
process
human
valid
authent
fulllength
gpc
opplig
et
al
consid
promis
therapeut
target
novel
antivir
drug
combat
human
pathogen
arenavirus
depend
newli
emerg
pathogen
arenaviru
assess
new
sensor
may
open
possibl
rapid
intervent
sensor
use
assess
process
arenaviru
gpc
orthologu
deriv
speci
shed
light
complex
ecolog
arenavirus
conceptu
sensor
platform
develop
base
lesson
learn
arenaviru
gpc
cleavag
may
applic
human
proteas
respons
process
plethora
viral
envelop
gp
wide
rang
speci
virolog
research
commun
platform
may
serv
rapid
costeffect
evalu
viral
gp
process
human
proteas
may
contribut
prepared
threat
emerg
virus
